Five Glutathione S-Transferase Gene Variants in 23,452 Cases of Lung Cancer and 30,397 Controls: Meta-Analysis of 130 Studies
2006

Gene Variants and Lung Cancer Risk

Sample size: 23452 publication Evidence: moderate

Author Information

Author(s): Ye Zheng, Song Honglin, Higgins Julian P. T, Pharoah Paul, Danesh John

Primary Institution: University of Cambridge

Hypothesis

Do variants in the GST detoxification genes affect the risk of lung cancer?

Conclusion

The risk of lung cancer is not strongly associated with the I105V and A114V polymorphisms in the GSTP1 gene or with GSTM3 intron 6 polymorphism.

Supporting Evidence

  • The meta-analysis included data from over 23,000 lung cancer patients and 30,000 controls.
  • Overall, the relative risk for lung cancer associated with the GSTM1 null genotype was 1.22.
  • Analysis of larger studies showed non-significant associations for GSTM1 and GSTT1 null genotypes.
  • Ethnic background was a significant source of heterogeneity among studies.

Takeaway

Scientists looked at how certain gene changes might affect the chances of getting lung cancer, but they found that these changes don't seem to make a big difference.

Methodology

Literature-based meta-analysis of 130 studies involving genetic association studies of five GST polymorphisms.

Potential Biases

There is a possibility of publication bias, particularly for the GSTM1 null genotype.

Limitations

Data on some variants were sparse, making it difficult to assess their impact reliably, and the study lacked individual participant data for more detailed analyses.

Participant Demographics

48% of lung cancer cases were individuals of European continental ancestry, 37% East Asian, and 15% of other ethnic origins.

Statistical Information

Confidence Interval

95% CI: 1.14–1.23

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030091

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication